PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $13,000 | -78.3% | 61,362 | -51.7% | 0.00% | -75.0% |
Q2 2019 | $60,000 | +9.1% | 127,064 | 0.0% | 0.00% | +33.3% |
Q1 2019 | $55,000 | +41.0% | 127,064 | +0.0% | 0.00% | +50.0% |
Q4 2018 | $39,000 | -57.1% | 127,062 | -0.0% | 0.00% | -50.0% |
Q3 2018 | $91,000 | +225.0% | 127,064 | +107.1% | 0.00% | +300.0% |
Q2 2018 | $28,000 | -58.8% | 61,364 | -51.7% | 0.00% | -66.7% |
Q1 2018 | $68,000 | -20.0% | 127,062 | 0.0% | 0.00% | -40.0% |
Q4 2017 | $85,000 | – | 127,062 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,825,000 | $1,206,000 | 0.39% |
Zhang Financial LLC | 45,000 | $33,000 | 0.02% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 472,553 | $313,000 | 0.01% |
MEITAV INVESTMENT HOUSE LTD | 127,062 | $85,000 | 0.01% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $215,000,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $200,000 | 0.00% |
Renaissance Technologies | 1,993,500 | $1,318,000 | 0.00% |
WEDBUSH SECURITIES INC | 15,000 | $10,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 57,127 | $38,000 | 0.00% |
Psagot Value Holdings Ltd. | 29,193 | $20,000 | 0.00% |